Mefloquine miscues Despite known risks of antimalarial medication, the Department of Defense issued mefloquine to U.S. troops for nearly a quarter century. Now, VA disability examiners may be misattributing its chronic adverse effects to PTSD. By M. Todd Hunter 18

Issue Articles

Mefloquine miscues

M. Todd Hunter

Visit Article: http://digital.dav.org/article/Mefloquine+miscues/3606475/650738/article.html.

Issue List

May/June 2021

March/April 2021

January/February 2021

November/December 2020

September/October 2020

July/August 2020

May/June 2020

March/April 2020

January/February 2020

November/December 2019

September/October 2019

July/August 2019

May/June 2019

March/April 2019

January/February 2019

November/December 2018

September/October 2018

July/August 2018

May/June 2018

March/April 2018

January/February 2018

November/December 2017

September/October 2017

July/August 2017

May/June 2017

March/April 2017

January/February 2017

November/December 2016

2016 AVDLM Book

September/October 2016

July/August 2016

May/June 2016

March/April 2016

January/February 2016

November/December 2015

September/October 2015

July/August 2015

May/June 2015

March/April 2015

January/February 2015

November/December 2014

September/October 2014

July/August 2014

May/June 2014

March/April 2014